Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 181 participants.

Also called NCT02470403

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose other
Phase
Phase 2
Enrolled
  • 181 participants (enrolled count) (from the registry)
Sponsor
  • Novartis Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02470403
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02470403. Randomized; quadruple masking; primary purpose other. Start 2015-06-05 (actual); primary completion 2016-04-04 (actual). Results posted on 2017-05-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index
Condition
Elevated Body Mass Index
Intervention (Drug)
LIK066
Intervention (Drug)
Placebo
Lead sponsor
Novartis Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct02470403
Content hash
c23e8f03c5cde36c4f0f8f8287bf61cb9877e7b0e986bc6cf1b97e7baa5669da